new hope for ovarian sufferers, page-4

CA-125 is a marker used in blood to test for certain cancers.
Early diagnosis will be as important as finding vaccines.

Earlier diagnosis + earlier treatment = better outcome for patient.

Eventually there will no need (at least less reliance) for chemotherapy as we will be able to catch cancer in it's early stages and eliminate it in a more natural way with vaccines such as Provenge and CVac.

Will this news have an affect on the share price today? No, probably not.

If CVac goes to market will technologies like this be significant? Absolutely, more so for patients...but denitely good news if Prima had a product like CVac in the market that could be used in early stage treatment as well. (which CVac would eventually be used for if proven successful in Phase 3)